Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis (ARCADIA)

This study has been completed.
Sponsor:
Collaborator:
Agenzia Italiana del Farmaco
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research
ClinicalTrials.gov Identifier:
NCT00985322
First received: September 25, 2009
Last updated: May 30, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2016
  Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)